Metabolic disturbances in diabetic cardiomyopathy (original) (raw)

References

  1. Palumbo PJ, Elveback CR, Conolly DC: Coronary artery disease and congestive heart failure in the diabetic: Epidemiological aspects. The Rochester Diabetes Project. In: RC Scott (ed). Clinical Cardiology and Diabetes. Futura, New York, 1981, p 13
    Google Scholar
  2. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham Study. JAMA 229: 1749–1754, 1974
    Google Scholar
  3. Ledet B, Neubauer B, Christnesen NJ, Lundback K: Diabetic cardiopathy. Diabetologia 16: 207–209, 1979
    Google Scholar
  4. Hamby RI, Zoneraich S, Sherman L: Diabetic cardiomyopathy. JAMA 229: 1749–1754, 1974
    Google Scholar
  5. Regan TJ, Lyons MM, Ahmed SS: Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 885–889, 1977
    Google Scholar
  6. Miller TB Jr: Cardiac performance of isolated perfused hearts from alloxan diabetic rats. Am J Physiol 236: 808–812, 1979
    Google Scholar
  7. Fein FS, Sonnenblick EH: Diabetic cardiomyopathy. Prog Cardiovasc Res 27: 255–270, 1985
    Google Scholar
  8. Vadlamudi RVSV, Rodgers RL, McNeill JH: The effect of chronic alloxan-and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 60: 902–911, 1982
    Google Scholar
  9. Rodrigues B, McNeill JH: The diabetic heart: Metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26: 913–992, 1992
    Google Scholar
  10. Rodrigues B, Cam MC, McNeill JH: Myocardial substrate metabolism: Implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27: 169–179, 1995
    Google Scholar
  11. Gibbons GF: Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268: 1–13, 1990
    Google Scholar
  12. Rodrigues B, Grassby PF, Battell ML, Lee SYN, McNeill JH: Hypertriglyceridemia in experimental diabetes: Relationship to cardiac dysfunction. Can J Physiol Pharmacol 72: 447–455, 1994
    Google Scholar
  13. Mamo JCL, Hirano T, Sainsbury A, Fitzgerald AK, Redgrave TG: Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim Biophys Acta 1128: 132–138, 1992
    Google Scholar
  14. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 59: 8–13, 1979
    Google Scholar
  15. West KM, Ahuja MMS, Bennett PH, Czyzyk A, Mateo de Acosta O, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K, Keen H, Krolewski AS, Miki E, Schliack V, Teuscher A, Watkins PJ, Strober JA: The role of circulating glucose and triglyceride concentrations and their interactions with other ‘risk factors’ as determinants of arterial disease in nine diabetic population samples from the WHO Multi National study. Diabetes Care 6: 361–369, 1983
    Google Scholar
  16. Rodrigues B, Xiang H, McNeill JH: Effects of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats. Diabetes 37: 1358–1364, 1988
    Google Scholar
  17. Rodrigues B, Goyal RK, McNeil1 JH: Effects of hydralazine on streptozotocin-induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. J Pharmacol ExpTher 237: 292–299, 1986
    Google Scholar
  18. McNeill JH, Rodrigues B: Heart function in WKY diabetic rats. J Mol Cell Cardiol 28(6): A202, 1996
    Google Scholar
  19. Denton RM, Randle PJ: Concentration of glycerides and phospholipids in rat heart and gastronemius muscles. Effects of alloxan-diabetes and perfusion. Biochem J 104: 416–422, 1967
    Google Scholar
  20. Kenno KA, Severson DL: Lipolysis in isolated myocardial cells from diabetic rat hearts. Am J Physiol 249: 1024–1030, 1985
    Google Scholar
  21. Chattopadhyay J, Thompson EW, Schmid HHO: Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats. Lipids 25: 307–310, 1990
    Google Scholar
  22. Eckel RH: Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 320: 1060–1068, 1989
    Google Scholar
  23. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A: Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb 14: 1445–1451, 1994
    Google Scholar
  24. Hamosh M, Hamosh P: Lipoprotein lipase: Its physiological and clinical significance. Mol Aspects Med 6: 199–289, 1983
    Google Scholar
  25. Elkeles RS, Hambley J: The effects of fasting and streptozotocin on hepatic triglyceride lipase activity in the rat. Diabetes 26: 58–60, 1977
    Google Scholar
  26. Veeraraghavan K, Murthy K, Bauman MD, Shipp J: Regulation of triacylglycerol lipolysis in the perfused hearts of normal and diabetic rats. Diabetes 32: 718–722, 1983
    Google Scholar
  27. Nomura T, Hagino H, Gotoh M, Iguchi A, Sakamoto N: The effects of streptozotocin diabetes on tissue specific lipase activities in the rat. Lipids 19: 594–599, 1984
    Google Scholar
  28. Tavangar K, Murata Y, Pedersen ME, Goers JF, Hoffman AR, Kraemer FB: Regulation of lipoprotein lipase in the diabetic rat. J Clin Invest 90: 1672–1678, 1992
    Google Scholar
  29. O'Looney P, Maten MV, Vahouny GV: Insulin-mediated modifications of myocardial lipoprotein lipase and lipoprotein metabolism. J Biol Chem 258: 12994–13001, 1983
    Google Scholar
  30. Braun JEA, Severson DL: Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin. Am J Physiol 262: 663–670, 1992
    Google Scholar
  31. Rodrigues B, Severson DL: Acute diabetes does not reduce heparin-releasable lipoprotein lipase activity in perfused hearts from Wistar-Kyoto rats. Can J Physiol Pharmacol 71: 657–661, 1993
    Google Scholar
  32. Mamo JCL, Hirano T, Sainsbury A, Fitzgerald AK, Redgrave TG: Hypertriglyceridemia is exacerbated by slow lipolysis of triacylglycerol-rich lipoproteins in fed but not fasted streptozotocin diabetic rats. Biochim Biophys Acta 1128: 132–138, 1992
    Google Scholar
  33. Rutledge JC, Goldberg IJ: Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: Evidence that LpL increases LDL accumulation in vascular tissue. J Lipid Res 35: 1152–1160, 1994
    Google Scholar
  34. Fernandez-Borja M, Bellido D, Vilella E, Olivecrona G, Vilaro S: Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: Evidence for an LDL receptor-independent internalization pathway. J Lipid Res 37: 464–481, 1996
    Google Scholar
  35. Tsutsumi K, Inoue Y, Shina A, Murase T: Correction of hypertiglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase promoting agent, in STZ-induced diabetic rats. Diabetes 44: 414–417, 1995
    Google Scholar
  36. Liu K, Pierce GN: The effects of low density lipoprotein on Ca2+ transients in isolated rabbit cardiomyocytes. J Biol Chem 268: 3767–3775, 1993
    Google Scholar
  37. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000–1007, 1981
    Google Scholar
  38. Cushman SW, Wardzala LJ: Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem 255: 4758–4762, 1980
    Google Scholar
  39. Karnieli E, Zarnowski MJ, Hissin PJ, Simpson IA, Salans LB, Cushman SW: Insulin-stimulated translocation of glucose transport systems in the isolated rat adipose cell. J Biol Chem 256: 4772–4777, 1981
    Google Scholar
  40. Chen V, Ianuzzo CD, Fong BC, Spitzer JJ: The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes 33: 1078–1084, 1984
    Google Scholar
  41. Eckel J, Reinauer H: Insulin action on glucose transport in isolated cardiac myocytes: Signalling pathways and diabetes induced alterations. Biochem Soc Trans 18: 1135–1137, 1990
    Google Scholar
  42. Garvey WG, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transport system in rats: implication for diabetic cardiomyopathy. Am J Physiol 264: 837–844, 1993
    Google Scholar
  43. Randle PJ, Hales CN, Garland PB, Newsholme EA: The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785–789, 1963
    Google Scholar
  44. Chen V, Ianuzzo CD: Dosage effect of streptozotocin on rat tissue enzyme activities and glycogen concentration. Can J Physiol Pharmacol 60: 1251–1256, 1982
    Google Scholar
  45. Kerbey AK, Vary TC, Randle PJ: Molecular mechanisms regulating myocardial glucose oxidation. Basic Res Cardiol 80 (suppl 2): 93–96, 1985
    Google Scholar
  46. Wieland O, Siess E, Schulze-Wethmar FH, van Funcke HG, Winton B: Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: Effects of diabetes, fasting and refeeding on pyruvate dehydrogenase interconversion. Arch Biochem Biophys 143: 593–601, 1971
    Google Scholar

Download references